-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Zentalis Pharma, Lowers Price Target to $4

Benzinga·11/12/2025 17:25:45
Listen to the news
Morgan Stanley analyst Matthew Harrison maintains Zentalis Pharma (NASDAQ:ZNTL) with a Equal-Weight and lowers the price target from $8 to $4.